Quest diagnostics now offers biocept's liquid biopsy test for lung cancer, expanding its menu of advanced cancer diagnostics

Secaucus, n.j. and san diego, dec. 1, 2021 /prnewswire/ -- physicians in the united states can now order the liquid biopsy-based target selector™ ngs lung panel test directly from quest diagnostics (nyse: dgx), the nation's leading provider of diagnostic information services.

BIOC Ratings Summary

BIOC Quant Ranking